You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《全日速報》恆指升626點; 恆生科技指數升204點 阿里巴巴升逾7% 平安升逾6% 美團升逾6% 中電、上美股份、ASMPT創新高 成交暢旺
恆指全日收16,136點,升626點或4.0%。恆生科技指數報3,243點,升204點或6.7%。國指升256點或4.9%,報5,473點。大市成交額1,280.41億元。 活躍重磅股表現: 阿里巴巴(09988.HK) 收76元,上升7.6%; 平安(02318.HK) 收34.05元,上升6.7%; 美團(03690.HK) 收69.25元,上升6.5%; 港交所(00388.HK) 收243.6元,上升5.6%; 騰訊(00700.HK) 收290.8元,上升4%; 友邦(01299.HK) 收62.3元,上升3.4%; 建行(00939.HK) 收4.76元,上升3.3%; 異動恆指及國指成份股: 商湯-W(00020.HK) 收0.86元,上升10.3%; 龍湖(00960.HK) 收9.18元,上升10.1%; 碧桂園服務(06098.HK) 收5.59元,上升10%; 翰森製藥(03692.HK) 收12.8元,上升9.6%; 快手-W(01024.HK) 收43.7元,上升9%; 中芯(00981.HK) 收15.34元,上升8.6%; 海爾智家(06690.HK) 收24.1元,上升8.1%; 蒙牛(02319.HK) 收18.62元,上升8%; 阿里健康(00241.HK) 收3.03元,上升7.8%; 藥明康德(02359.HK) 收49元,上升7.8%; 京東健康(06618.HK) 收28.3元,上升7.8%; 京東集團(09618.HK) 收92.75元,上升7.8%; 吉利(00175.HK) 收8.19元,上升7.5%; 聯想集團(00992.HK) 收8.48元,上升7.5%; 中信股份(00267.HK) 收7.87元,上升7.2%; 理想汽車(02015.HK) 收119元,上升7.2%; 舜宇(02382.HK) 收48.45元,上升7%; 京東物流(02618.HK) 收7.29元,上升6.9%; 中生製藥(01177.HK) 收2.97元,上升6.8%; 石藥(01093.HK) 收6.14元,上升6.8%; 國壽(02628.HK) 收9.47元,上升6.8%; 信義光能(00968.HK) 收3.69元,上升6.6%; 小鵬汽車(09868.HK) 收33.45元,上升6.5%; 招行(03968.HK) 收29.55元,上升6.5%; 小米集團(01810.HK) 收12.9元,上升6.4%; 華潤啤酒(00291.HK) 收30元,上升6.4%; 康師傅控股(00322.HK) 收8.09元,上升6%; 周大福(01929.HK) 收11.26元,上升5.8%; 華潤置地(01109.HK) 收24.6元,上升5.8%; 海底撈(06862.HK) 收13.16元,上升5.8%; 李寧(02331.HK) 收19元,上升5.4%; 攜程集團-S(09961.HK) 收306.4元,上升5.4%; 比亞迪(01211.HK) 收180.9元,上升5.4%; 網易(09999.HK) 收165.5元,上升5.1%; 新奧能源(02688.HK) 收59.4元,上升5%; 信義玻璃(00868.HK) 收6.49元,上升5%; 藥明生物(02269.HK) 收18.16元,上升5%; 中電(00002.HK) 收67.35元,上升4.9%,創新高; 百度集團-SW(09888.HK) 收105.8元,上升4.9%; 安踏體育(02020.HK) 收70.85元,上升4.8%; 中國海外發展(00688.HK) 收12.22元,上升4.8%; 煤氣(00003.HK) 收5.77元,上升4.3%; 郵儲銀行(01658.HK) 收3.97元,上升3.9%; 百威亞太(01876.HK) 收13元,上升3.8%; 中行(03988.HK) 收3.02元,上升3.8%; 恆安(01044.HK) 收25.2元,上升3.7%; 國藥(01099.HK) 收21.3元,上升3.6%; 交行(03328.HK) 收4.84元,上升3.6%; 中國宏橋(01378.HK) 收5.73元,上升3.4%; 潤電(00836.HK) 收15.88元,上升3.4%; 中升控股(00881.HK) 收14.24元,上升3.3%; 農行(01288.HK) 收3.13元,上升3.3%; 農夫山泉(09633.HK) 收43.7元,上升3.2%; 工行(01398.HK) 收3.92元,上升3.2%; 東方海外(00316.HK) 收118.2元,上升3.1%; 異動綜合中小型股: 上美股份(02145.HK) 收38元,上升18.6%,創新高; 開拓藥業-B(09939.HK) 收1.75元,上升15.9%; 榮昌生物(09995.HK) 收17.8元,上升15.3%; 雲頂新耀-B(01952.HK) 收16.54元,上升13.8%; 華晨中國(01114.HK) 收3.89元,下跌13.6%; 途虎-W(09690.HK) 收19.28元,下跌13.5%; 康諾亞-B(02162.HK) 收34.35元,上升13%; 永達汽車(03669.HK) 收2.11元,上升12.2%; 海吉亞醫療(06078.HK) 收27.05元,上升11.8%; 世茂服務(00873.HK) 收0.98元,上升11.4%; 博安生物(06955.HK) 收10.54元,上升10.9%; 高鑫零售(06808.HK) 收1.22元,上升10.9%; 和黃醫藥(00013.HK) 收21.25元,上升10.9%; 康寧傑瑞製藥(09966.HK) 收4.28元,上升10.9%; 康方生物(09926.HK) 收43.15元,上升10.8%; 綠景中國地產(00095.HK) 收0.63元,上升10.5%; 樂普生物(02157.HK) 收3.28元,上升10.4%; 諾輝健康(06606.HK) 收17.54元,上升10.3%; 美的置業(03990.HK) 收4.51元,上升10.3%; 融創中國(01918.HK) 收1.2元,上升10.1%; 心通醫療(02160.HK) 收1.31元,上升10.1%; 中聯重科(01157.HK) 收4.93元,上升10%; 微創機器人-B(02252.HK) 收11.18元,上升10%; 四環醫藥(00460.HK) 收0.55元,上升10%; ASMPT(00522.HK) 收87.7元,上升1.8%,創新高; ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account